Recordati - M&A Summary and Business Overview

Medical ProductsCompany

Recordati M&A Summary

Recordati has acquired 18 companies. A total of 4 acquisitions came from private equity firms. It has also divested 2 assets.

Recordati’s largest acquisition to date was in 2007, when it acquired Orphan Europe SARL for $152M. It’s largest disclosed sale occurred in 2004, when it sold Sophartex S.A. to SynerLab SA for $19M. Recordati has acquired in 1 US state, and 10 countries. The Company’s most targeted sectors include life science (59%) and medical products (30%).

Recordati Business Overview

Where is Recordati headquartered?

Recordati is headquartered in Milan, Italy.

What is Recordati’s revenue?

Recordati disclosed revenue of 2,082M EUR for 2023 and 1,853M EUR for 2022.

How many employees does Recordati have?

Recordati has 4,455 employees.

What sector is Recordati in?

Recordati is a medical products company.

When was Recordati founded?

Recordati was founded in 1926.

M&A Summary

  • M&A Total Activity19
    • M&A Buy Activity17
    • M&A Sell Activity2
  • Total Sectors Invested 3
  • Total Countries Invested 10
  • M&A Buy/Sell Connections 8

Recordati

Recordati Industria Chimica e Farmaceutica S.p.A.

Via M. Civitali, 1,
Milan, 20148
Italy,
+39 02 487871
www.recordati.com

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 17 - - - - - 17
vol $935M $935M
Sell (0.0/yr) # 2 - - - - - 2
vol $19M $19M
  19

Most Recent M&A

Company Date Value Type
Tonipharm S.A.S. 2018-12-21 - Add-on Acquisition
Boulogne-Billancourt, France · www.tonipharm.com
Pro Farma AG 2016-07-14 17M CHF Add-on Acquisition
Baar, Switzerland · www.profarma.ch
Italchimici SpA 2016-05-31 146M EUR Add-on Acquisition
Metropolitan City, Italy · www.italchimici.net
Opalia Pharma S.A. 2013-11-01 - Add-on Acquisition
, Tunisia · www.opaliapharma.com.tn
Laboratorios Casen Fleet, S.L.U. 2013-09-09 105M EUR Add-on Acquisition
Pozuelo de Alarcón, Spain · www.casenfleet.com
Laboratorios Casen Fleet S.L.U. 2013-09-09 105M EUR Add-on Acquisition
Pozuelo de Alarcón, Spain
Lundbeck - Portfolio Of Products 2013-01-21 100M USD Divestiture
, United States
Farma-Projekt Sp. z o.o. 2012-08-23 19M PLN Add-on Acquisition
Krakow, Poland · www.farmaprojekt.pl
Dr. F. Frik Ilac A.S. 2011-07-01 130M USD Add-on Acquisition
Istanbul, Turkey
HERBACOS RECORDATI, s.r.o. 2009-01-19 21M EUR Add-on Acquisition
Pardubice, Czech Republic · www.recordati.cz
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 10 (59%) 658M (70%) 1 (50%) 19M (100%)
Medical Products 5 (29%) 172M (18%) 1 (50%) -
Healthcare Services 2 (12%) 105M (11%) - -
Total 17 $935M 2 $19M

By Geo

State/Country Buy Value Sell Value
France 5 166M 1 19M
Czech Republic 2 43M - -
Poland 1 19M 1 -
Spain 2 210M - -
Turkey 2 184M - -
Germany 1 51M - -
Italy 1 146M - -
Switzerland 1 17M - -
Tunisia 1 - - -
United States 1 100M - -
Domestic 1 (6%) 146M (16%) - -
Cross-border 16 (94%) 788M (84%) 2 (100%) 19M (100%)
Total 17 $935M 2 $19M

Deal Values

buy # Total
$100M to $1B 5 $638M
< $100M 8 $297M
TOTAL $935M
Largest Orphan Europe SARL
$152M (2007-09-28)
sell # Total
< $100M 1 $19M
TOTAL $19M
Largest Sophartex S.A.
$19M (2004-04-27)

M&A Connections

Deals
Acquired from
Investor(s)
18%
3 (18%)
Strategic(s)
12%
2 (12%)
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Recordati

Medical Products Companies , Italy Companies